Rüstem Yilmaz

Rüstem Yilmaz

Auto-generated profile, based on publicly available information

Rüstem Yilmaz

Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences Heidelberg University Mannheim Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in EMBO Reports
Verified
Journal Article
Closed access
DPDevesh C Pant
Devesh C Pant
JPJanani Parameswaran
Janani Parameswaran
LRLu Rao
Lu Rao
ILIsabel Loss
Isabel Loss
GCGanesh Chilukuri
Ganesh Chilukuri
JJJie Jiang
Jie Jiang

22 March 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DBDavid Brenner
David Brenner
KSKirsten Sieverding
Kirsten Sieverding
JSJahnavi Srinidhi
Jahnavi Srinidhi
SZSusanne Zellner
Susanne Zellner
CSChristopher Secker
Christopher Secker
JWJochen H. Weishaupt
Jochen H. Weishaupt
Heterozygous mutations in the TBK1 gene can cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The majority of TBK1-ALS/FTD patients carry deleterious loss-of-expression mutations, and it is still unclear which TBK1 function leads to neurodegeneration. We investigated the impact of the pathogenic TBK1 missense variant p.E696K, which does not abolish protein expression, but leads to a selective loss of TBK1 binding to the autophagy adaptor protein and TBK1 substrate optineurin. Using organelle-specific proteomics, we found that in a knock-in mouse model and human iPSC–derived motor neurons, the p.E696K mutation causes presymptomatic onset of autophagolysosomal dysfunction in neurons precipitating the accumulation of damaged lysosomes. This is followed by a progressive, age-dependent motor neuron disease. Contrary to the phenotype of mice with full Tbk1 knock-out, RIPK/TNF-α–dependent hepatic, neuronal necroptosis, and overt autoinflammation were not detected. Our in vivo results indicate autophagolysosomal dysfunction as a trigger for neurodegeneration and a promising therapeutic target in TBK1-ALS/FTD.

13 August 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
RMRasem Mustafa
Rasem Mustafa
CRChahinaz Rawas
Chahinaz Rawas
NMNadja Mannal
Nadja Mannal
GKGrzegorz Kreiner
Grzegorz Kreiner
BSBjörn Spittau
Björn Spittau
RPRosanna Parlato
Rosanna Parlato
Primary cilia (PC) are microtubule-based protrusions of the cell membrane transducing molecular signals during brain development. Here, we report that PC are required for maintenance of Substantia nigra (SN) dopaminergic (DA) neurons highly vulnerable in Parkinson’s disease (PD). Targeted blockage of ciliogenesis in differentiated DA neurons impaired striato-nigral integrity in adult mice. The relative number of SN DA neurons displaying a typical auto-inhibition of spontaneous activity in response to dopamine was elevated under control metabolic conditions, but not under metabolic stress. Strikingly, in the absence of PC, the remaining SN DA neurons were less vulnerable to the PD neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP). Our data indicate conserved PC-dependent neuroadaptive responses to DA lesions in the striatum. Moreover, PC control the integrity and dopamine response of a subtype of SN DA neurons. These results reinforce the critical role of PC as sensors of metabolic stress in PD and other disorders of the dopamine system.

21 November 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
RYRüstem Yilmaz
Rüstem Yilmaz
KSKatalin Szakszon
Katalin Szakszon
AAAnna Altmann
Anna Altmann
UAUmut Altunoglu
Umut Altunoglu
LSLeyli Senturk
Leyli Senturk
GBGuntram Borck
Guntram Borck

7 May 2020 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
Sher Alam KhanSher Alam Khan
Sher Alam Khan
MKMuhammad Adnan Khan
Muhammad Adnan Khan
NMNazif Muhammad
Nazif Muhammad
HBHina Bashir
Hina Bashir
NKNiamat Khan
Niamat Khan
NWNaveed Wasif
Naveed Wasif
Background: Amelogenesis imperfecta (AI) is a highly heterogeneous group of hereditary developmental abnormalities which mainly affects the dental enamel during tooth development in terms of its thickness, structure, and composition. It appears both in syndromic as well as non-syndromic forms. In the affected individuals, the enamel is usually thin, soft, rough, brittle, pitted, chipped, and abraded, having reduced functional ability and aesthetics. It leads to severe complications in the patient, like early tooth loss, severe discomfort, pain, dental caries, chewing difficulties, and discoloration of teeth from yellow to yellowish-brown or creamy type. The study aimed to identify the disease-causing variant in a consanguineous family. Methods: We recruited a consanguineous Pashtun family of Pakistani origin. Exome sequencing analysis was followed by Sanger sequencing to identify the pathogenic variant in this family. Results: Clinical analysis revealed hypomaturation AI having generalized yellow-brown or creamy type of discoloration in affected members. We identified a novel nonsense sequence variant c.1192C > T (p.Gln398*) in exon-12 of SLC24A4 by using exome sequencing. Later, its co-segregation within the family was confirmed by Sanger sequencing. The human gene mutation database (HGMD, 2019) has a record of five pathogenic variants in SLC24A4, causing AI phenotype. Conclusion: This nonsense sequence variant c.1192C > T (p.Gln398*) is the sixth disease-causing variant in SLC24A4, which extends its mutation spectrum and confirms the role of this gene in the morphogenesis of human tooth enamel. The identified variant highlights the critical role of SLC24A4 in causing a rare AI type in humans.

14 April 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
RYRüstem Yilmaz
Rüstem Yilmaz
KWKanchi Weishaupt
Kanchi Weishaupt
IVIvan Valkadinov
Ivan Valkadinov
AKAntje Knehr
Antje Knehr
DBDavid Brenner
David Brenner
JWJochen H. Weishaupt
Jochen H. Weishaupt
Objectives: Due to upcoming gene‐specific therapy approaches for ALS patients, understanding familial and sporadic ALS genetics is becoming increasingly important. In this study, we wanted to investigate underlying genetic causes for an SALS patient.Methods: We performed ALS gene panel sequencing and subsequent segregation analysis in the family.Results: Genetic studies suggest that a proportion of SALS cases has an oligogenic origin due to the combination of low‐effect size mutations in several ALS genes. Maximally three mutations in different ALS disease genes have been described in isolated ALS patients. Here, we report for the first time the co‐occurrence of rare nonsynonymous variants in four known ALS genes in a SALS patient (c.859G > A/p.Gly287Ser in TARDBP, c.304G > T/p.Glu102* in NEK1, c.3446C > A/p.Gly1149Val in ERBB4, and c.1015C > T/p.Arg339Trp in VEGFA). All four variants were unique for the patient, whereas up to three of these variants were detected in the unaffected family members, all older than the patient.Discussion: Our study suggests that SALS can be caused by the additive or synergistic action of low‐effect size mutations. Broader use of gene panel analysis or whole exome/genome sequencing may reveal a potentially treatable oligogenic causation in a higher percentage of SALS than previously thought.